Evalution and Development of Antidiabetic Effervescent Tablet of Caffeine
Researchers have emphasized the beneficial effects of coffee drinking on blood sugar management in humans. Conversely, the common medication used to treat type 2 diabetes is metformin. The purpose of this study was to investigate potential uses of coffee as an adjuvant to metformin or as a stand-alone treatment for type 2 diabetes Serum HbA levels were considerably lower in groups treated with black coffee (Group 3), metformin (Group 4), and black coffee with metformin (Group 5) than in the 1C diabetic control group (Group 2) (P<0.05).Acceptable salt of metformin, an acid compound or acid salt, an alkaline effervescing compound, one or more compressible binders, and one or more excipients are the components of the effervescent composition of metformin that is the subject of the invention. The weight ratio of the acid compound or acid salt (b) to the alkaline effervescing compound (c) must be greater than 2:1. Tablets and granules made from them are likewise covered by the invention. The invention also pertains to methods for producing effervescent tablets and granules, as well as a method for preparing said composition. The invention specifically targets formulations of metformin hydrochloride as well as the tablets and granules derived from them.
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-03-11
- DOI
- https://doi.org/10.5281/zenodo.15005457
- Primary Topic
- Research Data Management Practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00